Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPG 7909 and Herceptin in Metastatic Breast Cancer
NCT00031278Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2001
- Primary completion
- Jun 2003
- Countries
- 1
01
Overview
Phase 2, open-label trial of agatolimod in breast cancer, sponsored by Pfizer. Started Oct 2001; status: completed.
02
Drugs
agatolimod
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00031278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031278.